Reporting standards for adverse events after medical device use in the peripheral vascular system

Journal of Vascular Surgery

Volumn 58, Issue 3, 2013, Pages 776-786

  Ouriel, Kenneth ^a   Fowl, Richard J ^b   Davies, Mark G ^c   Forbes, Thomas L ^d   Gambhir, Raghvinder P S ^e   Morales, Jose Pablo ^f   Ricci, Michael A ^g  

^a Syntactx   (United States)

^b MAYO CLINIC   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e ARMY HOSPITAL   (India)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g Central Maine Heart and Vascular Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; ARTICLE; DATA ANALYSIS; DEVICE APPROVAL; DEVICE SAFETY; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HUMAN; INFORMATION PROCESSING; MEDICAL DEVICE; MEDICAL DEVICE COMPLICATION; MEDICAL DEVICE REGULATION; MORTALITY; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR SYSTEM; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL STANDARD; REPEAT PROCEDURE; STANDARDIZATION; STATISTICAL ANALYSIS;

CLINICAL TRIALS AS TOPIC; CLINICAL TRIALS DATA MONITORING COMMITTEES; DATA INTERPRETATION, STATISTICAL; ENDOVASCULAR PROCEDURES; EQUIPMENT DESIGN; ETHICS COMMITTEES; ETHICS COMMITTEES, RESEARCH; GOVERNMENT REGULATION; HUMANS; PERIPHERAL VASCULAR DISEASES; PRODUCT SURVEILLANCE, POSTMARKETING; RESEARCH DESIGN; TERMINOLOGY AS TOPIC;

EID: 84883187834     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2013.06.059     Document Type: Article

References (28)

1. The Society for Vascular Surgery. Bylaws: Article II. Objectives. Available at: http://www.vascularweb.org/about/Pages/bylaws.aspx. Accessed February 17, 2013.
2. G. Crowley EU and US clinical investigation adverse event reporting Med Device Technol 15 2004 30 32
3. Agency Information Collection Activities Submission for Office of Management and Budget Review Comment Request Investigational Device Exemptions Reports and Records Fed Regist 77 2012 71601 71603
4. W.F. Pritchard Jr., D.B. Abel, and J.W. Karanian The US Food and Drug Administration investigational device exemptions (IDE) and clinical investigation of cardiovascular devices: information for the investigator J Vasc Surg 29 1999 566 574
5. "Investigational device exemptions. Selecting investigators and monitors.," Title 21 Code of Federal Regulations, Pt. 812.43. 2012 ed.
6. ClinicalTrials.gov. Gobal regulatory agencies. Available at: http://www.clinicaltrials.com/industry/regulatory-agencies.htm. Accessed January 13, 2013.
7. P. Gupta, M.D. Janodia, P.C. Jagadish, and N. Udupa Medical device vigilance systems: India, US, UK, and Australia Med Devices (Auckl) 3 2010 67 79
8. T. Tominaga, Y. Ando, and T. Kondo International vision and strategy for drug regulatory authority: the PMDA's international vision Clin Pharmacol Ther 92 2012 349 351
9. W.J. Ziegler, and S.M. Perren Standards, guidelines and principles for clinical trials: medical products Swiss Surg 1995 81 83
10. International medical device regulators forum. Available at: http://www.imdrf.org/index.asp. Accessed February 25, 2013.
11. U.S. Department of Health and Human Services. Guidance for clinical investigators, sponsors, and IRBs. Adverse event reporting to IRBs - improving human subject protection. Washington, DC: Office of the Commissioner (OC) Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Devices and Radiological Health (CDRH) Office of Good Clinical Practice; January 2009.
12. U.S. Department of Health and Human Services. Code of Federal Regulations. Title 45. Public welfare. Department of Health and Human Services. Part 46. Protection of human subjects. Available at: http://www.hhs.gov/ohrp/ humansubjects/guidance/45cfr46.html. Accessed February 17, 2013.
13. U.S. Food and Drug Administration Form for reporting serious adverse events and product problems with human drug and biological products and devices; availability - FDA. Notice Fed Regist 58 1993 31596 31614
14. Lowe N, Scott WL. Medical device reporting for user facilities. Rockville, MD: Department of Health and Human Services, Public Health Services, Food and Drug Administration; April 1996.
15. U.S. Food and Drug Administration. Manufacturer and user facility device experience database (MAUDE). Available at: http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/PostmarketRequirements/ReportingAdverseEvents/ ucm127891.htm. Accessed February 17, 2013.
16. World Health Organization. Medical devices. Available at: http://www.who.int/medical-devices/policies/en/. Accessed February 27, 2013.
17. ISO 14155: Clinical investigation of medical devices for human subjects - good clinical practice 2 ed. 2011 International Organization for Standardization Geneva, Switzerland
18. U.S. Food and Drug Administration. What is a serious adverse event? Available at: www.fda.gov/safety/medwatch/howtoreport/ucm053087.htm. Accessed February 17, 2013.
19. Valiant CAPTIVIA Post-market Registry (VCOUS). Available at: http://clinicaltrials.nlm.nih.gov/ct2/show/NCT01181947. Accessed January 13, 2013.
20. Endurant Stent Graft Natural Selection Global Postmarket Registry. Available at: http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00870051. Accessed January 13, 2013.
21. D.B. Abel, H.G. Beebe, M.M. Dedashtian, M.C. Morton, M. Moynahan, and L.J. Smith Preclinical testing for aortic endovascular grafts: results of a Food and Drug Administration workshop J Vasc Surg 35 2002 1022 1028
22. J. May, G.H. White, and J.P. Harris Devices for aortic aneurysm repair Surg Clin North Am 79 1999 507 527
23. "Medical device reporting," Title 21 Code of Federal Regulations, Pt. 803.3. 2012 ed.
24. M.F. Fillinger, R.K. Greenberg, J.F. McKinsey, and E.L. Chaikof Reporting standards for thoracic endovascular aortic repair (TEVAR) J Vasc Surg 52 2010 1022 1033 1033
25. E.L. Chaikof, J.D. Blankensteijn, P.L. Harris, G.H. White, C.K. Zarins, and V.M. Bernhard Reporting standards for endovascular aortic aneurysm repair J Vasc Surg 35 2002 1048 1060
26. Hicks KA, Hung H, Mahaffey KW, Mehran R, Nissen SE, Stockbridge NL, et al. Standardized definitions for end point events in cardiovascular trials. Draft. Available at: http://www.clinpage.com/images/uploads/endpoint-defs-11-16- 2010.pdf. Accessed March 12, 2103.
27. D.W. Raisch, W.G. Troutman, M.R. Sather, and P.J. Fudala Variability in the assessment of adverse events in a multicenter clinical trial Clin Ther 23 2001 2011 2020
28. U.S. Department of Health and Human Services. Guidance for clinical trial sponsors: establishment and operation of clinical trial data monitoring committees. Rockville, MD: U.S. Department of Health and Human Services. Food and Drug Administration; March 2006.